Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Annales Pharmaceutiques Francaises|December 8, 2025
[Clinical oncology pharmacy: French current situation of pharmaceutical interventions in production units in 2024]Caroline Streicher, Florence Ranchon, Florian Slimano, et al.
Oncotarget|March 9, 2018
Recurrent extraneural sonic hedgehog medulloblastoma exhibiting sustained response to vismodegib and temozolomide monotherapies and inter-metastatic molecular heterogeneity at progressionGregorio J Petrirena, Julien Masliah-Planchon, Quentin Sala, et al.
Scientific Reports|June 5, 2017
A simple and rapid LC-MS/MS method for therapeutic drug monitoring of cetuximab: a GPCO-UNICANCER proof of concept study in head-and-neck cancer patientsFrançois Becher, Joseph Ciccolini, Diane-Charlotte Imbs, et al.
European Journal of Haematology|July 19, 2019
Efficacy and safety of autologous stem cell transplantation after induction therapy with lenalidomide, bortezomib, and dexamethasoneRobin Arcani, Geoffroy Venton, Julien Colle, et al.
Bulletin Du Cancer|June 20, 2022
[Locally advanced or metastatic bladder cancer: Identification of barriers and levers of patients' pathway in France]Nadine Houédé, Cécile Flahault, Marine Gross-Goupil, et al.
Anti-Cancer Drugs|May 31, 2008
High-dose methotrexate in adults with osteosarcoma: a population pharmacokinetics study and validation of a new limited sampling strategyCharlotte Dupuis, Cedric Mercier, Chenguang Yang, et al.
Annales Pharmaceutiques Francaises|October 10, 2025
The evolving role of Hospital Oncology Pharmacists (HOPs) in assessing therapeutic innovations and managing toxicities in cancer careFlorence Ranchon, Florian Slimano, Maha Ayyoub, et al.
Therapeutic Drug Monitoring|August 4, 2006
Therapeutic drug monitoring for dose individualization of Cisplatin in testicular cancer patients based upon total platinum measurement in plasmaSébastien Salas, Cédric Mercier, Joseph Ciccolini, et al.
Cancer Treatment Reviews|July 6, 2020
Cancer, immune suppression and Coronavirus Disease-19 (COVID-19): Need to manage drug safety (French Society for Oncology Pharmacy [SFPO] guidelines)Florian Slimano, Amandine Baudouin, Jérémie Zerbit, et al.
Therapeutic Drug Monitoring|April 22, 2006
Dose individualization of carboplatin after a 120-hour infusion schedule: higher dose intensity but fewer toxicitiesCédric Mercier, Joseph Ciccolini, Bertrand Pourroy, et al.
Pageof 5